IL6 and astrocytoma (excluding glioblastoma): To evaluate the IL-6-inducing activity of PRP and NP in human astrocytoma U87 cells, the polypeptide complex PRP and its nonapeptide fragment were added to the cells at doses of 0.1 or 10 μg/ml.